PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2.95%
Net income growth under 50% of AVGO's 24.28%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.47%
Some D&A expansion while AVGO is negative at -14.26%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
75.00%
Lower deferred tax growth vs. AVGO's 248.94%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
48.00%
SBC growth while AVGO is negative at -6.52%. John Neff would see competitor possibly controlling share issuance more tightly.
-572.34%
Both reduce yoy usage, with AVGO at -133.33%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-95.83%
Both yoy AR lines negative, with AVGO at -392.50%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-219.15%
Both reduce yoy inventory, with AVGO at -62.77%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
120.37%
A yoy AP increase while AVGO is negative at -100.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-181.37%
Negative yoy usage while AVGO is 81.18%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-500.00%
Negative yoy while AVGO is 176.47%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.04%
Both yoy CFO lines are negative, with AVGO at -1.55%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
65.44%
Some CapEx rise while AVGO is negative at -14.77%. John Neff would see competitor possibly building capacity while we hold back expansions.
-97.06%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-7.87%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
2.44%
We have some liquidation growth while AVGO is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
50.00%
Growth well above AVGO's 11.11%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
25.17%
We have mild expansions while AVGO is negative at -718.00%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment above 1.5x AVGO's 66.54%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
9.62%
We slightly raise equity while AVGO is negative at -98.25%. John Neff sees competitor possibly preserving share count or buying back shares.
-314.79%
Both yoy lines negative, with AVGO at -1065.04%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.